新CEO上任：将引领泰尔茂比司特（Terumo BCT）开创新天地
01 avr. 2019 06h00 HE
|
Terumo BCT
美国科罗拉多州莱克伍德报道, April 01, 2019 (GLOBE NEWSWIRE) -- 安托娜·高雯（Antoinette Gawin）致力于扩大生物医学公司泰尔茂比司特（Terumo BCT）的规模，带领其突破传统界限，与血液中心和医院合作，为细胞治疗技术和再生医学等快速增长的医疗保健领域服务。泰尔茂比司特（Terumo...
New CEO Leads Terumo BCT’s Ambition to Shape the Future of Blood and Cell Technologies in Healthcare
01 avr. 2019 06h00 HE
|
Terumo BCT
LAKEWOOD, Colo., April 01, 2019 (GLOBE NEWSWIRE) -- Antoinette Gawin is expanding Terumo BCT, a biomedical company, beyond its heritage in working with blood centers and hospitals to serve rapidly...
UniCAR Therapy와 Terumo BCT CAR T-Cell, 치료법 발전 위해 제휴 맺고 중국 상하이에 China Center of Excellence 설립
10 oct. 2018 19h11 HE
|
Terumo BCT
콜로라도주 레이크우드, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Shanghai UniCAR-Therapy Bio-Medicine Technology Co.가 Terumo BCT와 제휴를 맺고 키메릭 항원 수용체(CAR) T세포 치료에 필요한 세포 치료 제조 프로세스를 자동화하기 위해 Terumo BCT의 세포 증식 장치를 채택했다....
ユニCARセラピーとテルモBCT、CAR T細胞療法を進化させ、中国上海にセンターオブエクセレンスを設立するために提携
09 oct. 2018 22h11 HE
|
Terumo BCT
コロラド州レイクウッド, Oct. 10, 2018 (GLOBE NEWSWIRE) -- 上海UniCARセラピー･バイオメディシン･テクノロジー社 (Shanghai UniCAR-Therapy Bio-Medicine Technology Co.、ユニCAR) は、キメラ抗原受容体 (CAR) T細胞療法のための細胞療法製造プロセスを自動化するにあたり、テルモBCT (Terumo...
UniCAR Therapy dan Terumo BCT Bekerjasama untuk Melanjutkan Terapi Sel T CAR dan Mencipta Center of Excellence Shanghai, China
09 oct. 2018 22h11 HE
|
Terumo BCT
LAKEWOOD, Colo., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Shanghai UniCAR-Therapy Bio-Medicine Technology Co. memilih Terumo BCT dan peranti pertambahan sel untuk mengautomasikan proses pengilangan terapi...
UniCAR正与Terumo BCT合作推动嵌合抗原受体T细胞疗法并在中国上海设立卓越中心
09 oct. 2018 22h11 HE
|
Terumo BCT
科罗拉多州莱克伍德, Oct. 10, 2018 (GLOBE NEWSWIRE) -- 上海UniCAR生物医药科技有限公司选择通过Terumo BCT及其细胞扩增装置，实现嵌合抗原受体（CAR）T细胞疗法制造工艺的自动化。私营的UniCAR将于11月在上海设立Terumo BCT技术的卓越中心。 Terumo...
UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence
09 oct. 2018 22h11 HE
|
Terumo BCT
LAKEWOOD, Colo., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell therapy manufacturing...
U.S. FDA Approves Terumo BCT’s Sodium Citrate 4% w/v Anticoagulant Solution Amid Shortage
18 juil. 2018 10h04 HE
|
Terumo BCT
Lakewood, Colorado, USA, July 18, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) recently approved Terumo BCT’s Sodium Citrate 4% w/v Anticoagulant Solution USP, indicated for...